DealBook: Dendreon, Maker of Prostate Cancer Drug Provenge, Files for Bankruptcy
Monday, November 10, 2014 - 15:20
in Mathematics & Economics
Dendreon filed for bankruptcy protection on Monday after sales of Provenge fell way short of expectations and the company could not pay off a huge debt coming due.